Functional responses of human β1 adrenoceptors with defined haplotypes for the common 389R>G and 49S>G polymorphisms

Pharmacogenetics

Volumn 14, Issue 6, 2004, Pages 343-349

  Sandilands, Alastair ^a   Yeo, Giles ^a   Brown, Morris J ^a   O'Shaughnessy, Kevin M ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

1 adrenoceptors ( 1 AR); Cyclic AMP; Desensitization; Genetic polymorphism; Haplotype responses; Receptor down regulation

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; COMPLEMENTARY DNA; CYANOPINDOLOL I 125; CYCLIC AMP; ISOPRENALINE;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; CELLS, CULTURED; CYCLIC AMP; DNA, COMPLEMENTARY; DOWN-REGULATION; GENOTYPE; HAPLOTYPES; HUMANS; IODINE RADIOISOTOPES; ISOPROTERENOL; KIDNEY; LIGANDS; PINDOLOL; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-1;

EID: 3042647164     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200406000-00003     Document Type: Article

References (20)

1. Small KM, McGraw DW, Liggett SB. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 2003; 43:381-411.
2. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, et al. Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N Engl J Med 1982; 307:205-211.
3. Maqbool A, Hall AS, Ball SG, Balmforth AJ. Common polymorphisms of β1-adrenoceptor: identification and rapid screening assay. Lancet 1999; 353:897.
4. Mason DA, Moore JD, Green SA, Liggett SB. A gain-of-function polymorphism in a G-protein coupling domain of the human β1-adrenergic receptor. J Biol Chem 1999; 274:12670-12674.
5. Tesson F, Charron P, Peuchmaurd M, Nicaud V, Cambien F, Tiret L, et al. Characterisation of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol 1999; 31:1025-1032.
6. 1-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 2000; 21:1853-1858.
7. 1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharm 2002; 39:155-160.
8. Levin MC, Marullo S, Muntaner O, Andersson B, Magnusson Y. The myocardium-protective Gly-49 variant of the β-1 adrenergic receptor exhibits constitutive activity and increased desensitization and downregulation. J Biol Chem 2002; 277:30429-30435.
9. Podlowski S, Wengel K, Luther H, Muller J, Bramlage P, Baumann G, et al. β-1 adrenoceptor gene variations: a role in IDCM. J Mol Med 2000; 78:87-93.
10. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta-1 adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33:9414-9419.
11. O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ. The gain of function variant (R389G) of the β-1 AR does not influence blood pressure or response to β-blockade in hypertensive subjects. Clin Sci (Lond.) 2000; 99:233-238.
12. 1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002; 70:935-942.
13. Ryden M, Hoffstedt J, Erikkson P, Bringman S, Amer P. The Arg 389 Gly β-1 adrenergic receptor gene polymorphism and human fat cell lipolysis. Int J Obes Relat Metab Disord 2001; 25:1599-1603.
14. Sandilands AJ, O'Shaughnessy KM, Brown MJ. Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 β-1 adrenoceptors versus Gly389 β-1 adrenoceptors in isolated human atrial myocardium. Br J Pharm 2003; 138:386-392.
15. Suzuki T, Nguyen CT, Nantel F, Bonin H, Valiquette M, Frielle T, Bouvier M. Distinct regulation of beta-1 and beta-2 adrenergic receptors in Chinese hamster fibroblasts. Mol Pharm 1992; 41:542-548.
16. Shiina T, Kawasaki A, Nagao T, Kurose H. Interaction with beta-arrestin determines the difference in internalization behaviour between beta1- and beta2-adrenergic receptors. J Biol Chem 2000; 275:29082-90.
17. Duprez L, Parma J, Costagliola S, Hermans J, Van Sande J, Dumont JE, Vassart G. Constitutive activity of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 1997; 409:469-474.
18. Green SA, Liggett SB. A proline rich region of the third intracellular loop imparts phenotypic beta-1 versus beta-2 adrenergic receptor coupling and sequestration. J Biol Chem 1994; 269:26215-26219.
19. Frielle T, Collins S, Daniel KW, Caron MG, Lefkowitz RJ, Kobilka BK. Cloning of the cDNA for the beta-1 adrenergic receptor. Proc Natl Acad Sci U S A 1987; 84:7920-7924.
20. Rathz DA, Gregory KN, Fang Y, Brown KA, Liggett SB. Heirarchy of polymorphic variation and desensitization permutations relative to β-1 and β-2 adrenergic receptor signalling. J Biol Chem 2003; 278:10784-10789.